Liverpool has the largest concentration of ‘whole picture’ focussed public sector R&D expertise in infection in the UK.
The Wolfson Foundation donated £1.1m towards world-class laboratory facilities at the Liverpool Life Sciences Accelerator, a hub for life sciences, enabling clinicians, academics and industry to collaborate in research and innovation to develop their ideas into the very latest life-saving treatments. The building houses a new Clinical Research Unit, supported by Unilever, which will enable us to conduct clinical trials with more patients in less time. This will have a significant impact on our work in pneumonia, the largest cause of vaccine preventable deaths in children under five globally.